Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

U.S. Panel Recommends Giving First Covid Vaccines to Health Workers, Nursing Homes--Update

12/01/2020 | 05:59pm EST

By Peter Loftus and Jared Hopkins

A federal vaccine advisory panel voted Tuesday to recommend that health-care workers and residents of long-term care facilities be the first to receive any Covid-19 vaccine doses from the limited supply that will be available initially.

The recommendations from the panel, which advises the Centers for Disease Control and Prevention, apply to about 21 million health-care workers and three million residents of long-term care facilities.

Federal officials have said they expect there will be about 40 million doses available in December. The initial vaccines available are given in two doses three or four weeks apart, so there may be enough for 20 million people to be vaccinated in the early weeks. Supplies are expected to increase during 2021.

U.S. health regulators are expected to decide in the coming weeks whether to authorize the emergency use of two Covid-19 vaccines, one from Pfizer Inc. and BioNTech SE and another from Moderna Inc. The companies have been manufacturing doses but it could take several months to make enough to vaccinate the broader population.

The CDC usually follows the recommendation of its advisory panel, and its decision is expected by the time any shots are authorized. States, which will ultimately decide how to allocate Covid-19 vaccine supplies, have been waiting for the recommendations. States have until Friday to indicate to the federal government where they want their initial doses sent.

(END) Dow Jones Newswires

12-01-20 1759ET

Stocks mentioned in the article
ChangeLast1st jan.
BIONTECH SE -4.02% 101.59 Delayed Quote.24.62%
MODERNA, INC. -0.05% 129.65 Delayed Quote.24.10%
PFIZER INC. -0.14% 36.7 Delayed Quote.-0.30%
All news about MODERNA, INC.
03:57pMODERNA : Vaccination campaign gets underway in nine Cree communities in norther..
AQ
03:55aSwiss to get Moderna vaccine in tranches until mid-year - Blick
RE
01/16MODERNA : U.S. COVID-19 vaccine supplies strain to meet wider eligibility, secon..
RE
01/15PFIZER : Anger in states over pace of COVID-19 vaccine allotments
AQ
01/15MODERNA : WHO sees poorer countries getting first COVID vaccines this quarter
RE
01/1531.2 MLN DOSES OF COVID-19 VACCINES : U.s. cdc
RE
01/15COVID-19 VACCINES : Development, Distribution And Dosing
AQ
01/14EXCLUSIVE : India to treat homegrown COVID-19 vaccine same as AstraZeneca's
RE
01/14MODERNA : U.S. big-city mayors ask Biden for direct shipments of COVID-19 vaccin..
RE
01/14UK to step up coronavirus vaccinations -FT
RE
More news
Financials (USD)
Sales 2020 511 M - -
Net income 2020 -566 M - -
Net cash 2020 2 865 M - -
P/E ratio 2020 -108x
Yield 2020 -
Capitalization 51 304 M 51 304 M -
EV / Sales 2020 94,7x
EV / Sales 2021 4,51x
Nbr of Employees 1 100
Free-Float 90,0%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 136,60 $
Last Close Price 129,65 $
Spread / Highest target 42,7%
Spread / Average Target 5,36%
Spread / Lowest Target -46,8%
EPS Revisions
Managers and Directors
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
Noubar B. Afeyan Chairman
David W. Meline Chief Financial Officer
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.24.10%51 304
LONZA GROUP AG3.27%49 041
CELLTRION, INC.-8.36%40 715
IQVIA HOLDINGS INC.4.81%36 004
SEAGEN INC.6.06%33 601
HANGZHOU TIGERMED CONSULTING CO.,LTD0.37%21 655